Category Guide
Gutsy Moves in the IBD Biologics Market
The biologics market for inflammatory bowel disease (IBD) is rapidly evolving, with significant developments and increasing competition driving the field forward. June Seow, MPharm Senior Business Analyst for Lifescience Dynamics explains key trends shaping the market. Biologics Leading the Charge
29 May 2024
Stay ahead of trends and best practices
